Sign In
Buy SGHT
$4.34
+0 (+0%)
At Close: Jun 03, 2026
Sight Sciences, Inc. (SGHT) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
08:30pm, Wednesday, 13'th May 2026
Sight Sciences, Inc. (SGHT) Presents at Bank of America Global Healthcare Conference 2026 Prepared Remarks Transcript
Sight Sciences, Inc. (SGHT) Q1 2026 Earnings Call Transcript
05:01am, Thursday, 07'th May 2026
Sight Sciences, Inc. (SGHT) Q1 2026 Earnings Call Transcript
Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
08:31pm, Wednesday, 06'th May 2026
Although the revenue and EPS for Sight Sciences (SGHT) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall
Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates
07:31pm, Wednesday, 06'th May 2026
Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.28 per share a year ago.
Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance
04:05pm, Wednesday, 06'th May 2026
MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing in
Sight Sciences to Present at Two Upcoming Investor Conferences
04:05pm, Wednesday, 29'th Apr 2026
MENLO PARK, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing inno
Sight Sciences Announces the Release of its Sustainability Report
04:45pm, Wednesday, 22'nd Apr 2026
The Sustainability Report provides data for 2023 through 2025 on the Company's environmental, social, and governance initiatives The Sustainability Report provides data for 2023 through 2025 on the Co
Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026
04:05pm, Tuesday, 21'st Apr 2026
MENLO PARK, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing inno
Insider Selling: Sight Sciences (NASDAQ:SGHT) EVP Sells $10,615.30 in Stock
05:43am, Monday, 06'th Apr 2026
Sight Sciences, Inc. (NASDAQ: SGHT - Get Free Report) EVP Brenton Taylor sold 2,869 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price
Sight Sciences (NASDAQ:SGHT) CTO Sells $28,424.64 in Stock
05:42am, Monday, 06'th Apr 2026
Sight Sciences, Inc. (NASDAQ: SGHT - Get Free Report) CTO David Badawi sold 8,168 shares of Sight Sciences stock in a transaction that occurred on Thursday, April 2nd. The shares were sold at an avera
Paul Badawi Sells 29,244 Shares of Sight Sciences (NASDAQ:SGHT) Stock
05:57am, Sunday, 05'th Apr 2026
Sight Sciences, Inc. (NASDAQ: SGHT - Get Free Report) CEO Paul Badawi sold 29,244 shares of Sight Sciences stock in a transaction dated Wednesday, April 1st. The stock was sold at an average price of
MENLO PARK, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, in
Sight Sciences to Present at the 25th Annual Needham Healthcare Conference on April 13th
04:05pm, Monday, 30'th Mar 2026
MENLO PARK, Calif., March 30, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commerci
Court preserves jury's finding of willful infringement by Alcon, and awards past damages to Sight Sciences in excess of $34 million and ongoing royalties through November 2028 Court preserves jury's f
SAN DIEGO, March 06, 2026 (GLOBE NEWSWIRE) -- Johnson Fistel, PLLP is investigating potential claims on behalf of investors of Sight Sciences, Inc. (NASDAQ: SGHT). The investigation focuses on Sight S
